Cytotoxic T cell-driven immunity promotes ferroptosis in cancer cells; for instance, anti-PD-L1 antibody induces lipid peroxidation-dependent ferroptosis in tumor cells (Figure 1A), which made ferroptosis-related anticancer therapy a promising target (30). Here, CD274 is linked to neoplasm.